#ITI#Genetic diversity and selection regulates evolution of infectious bronchitis virus#FTI#
#IRE#Conventional and molecular epidemiologic studies have confirmed the ability of infectious bronchitis virus (IBV) to rapidly evolve and successfully circumvent extensive vaccination programs implemented since the early 1950s. IBV evolution has often been explained as variation in gene frequencies as if evolution were driven by genetic drift alone. However, the mechanisms regulating the evolution of IBV include both the generation of genetic diversity and the selection process. IBV's generation of genetic diversity has been extensively investigated and ultimately involves mutations and recombination events occurring during viral replication. The relevance of the selection process has been further understood more recently by identifying genetic and phenotypic differences between IBV populations prior to, and during, replication in the natural host. Accumulating evidence suggests that multiple environmental forces within the host, including immune responses (or lack thereof) and affinity for cell receptors, as well as physical and biochemical conditions, are responsible for the selection process. Some scientists have used or adopted the related quasispecies frame to explain IBV evolution. The quasispecies frame, while providing a distinct explanation of the dynamics of populations in which mutation is a frequent event, exhibits relevant limitations which are discussed herein. Instead, it seems that IBV populations evolving by the generation of genetic variability and selection on replicons follow the evolutionary mechanisms originally proposed by Darwin. Understanding the mechanisms underlying the evolution of IBV is of basic relevance and, without doubt, essential to appropriately control and prevent the disease. Â© American Association of Avian Pathologists.#FRE#
#IPC#coronavirus; evolution; genetic variation; infectious bronchitis virus; natural selection; phenotypic variation; quasispecies#FPC#
#IRF#Ammayappan A., Upadhyay C., Gelb Jr.J., Vakharia V.N., Identification of sequence changes responsible for the attenuation of avian infectious bronchitis virus strain Arkansas DPI, Arch. Virol., 154, pp. 495-499, (2009); 
Armesto M., Cavanagh D., Britton P., The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathoge-nicity, PLoS ONE, 4, (2009); 
Ballesteros M.L., Sanchez C.M., Enjuanes L., Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism, Virology, 227, pp. 378-388, (1997); 
Baric R.S., Yount B., Hensley L., Peel S.A., Chen W., Episodic evolution mediates interspecies transfer of a murine coronavirus, J. Virol., 71, pp. 1946-1955, (1997); 
Bellmunt A., May G., Zell R., Pring-Akerblom P., Verhagen W., Heim A., Evolution of poliovirus type i during 5.5 years of prolonged enteral replication in an immunodeficient patient, Virology, 265, pp. 178-184, (1999); 
Brimacombe K.R., Ladd A.N., Cloning and embryonic expression patterns of the chicken CELF family, Dev. Dyn., 236, pp. 2216-2224, (2007); 
Buttinelli G., Donati V., Fiore S., Marturano J., Plebani A., Balestri P., Soresina A.R., Vivarelli R., Delpeyroux F., Martin J., Fiore L., Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis, J. Gen. Virol., 84, pp. 1215-1221, (2003); 
Casais R., Dove B., Cavanagh D., Britton P., Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism, J. Virol., 77, pp. 9084-9089, (2003); 
Cavanagh D., Coronavirus IBV: Structural characterization of the spike protein, J. Gen. Virol., 64, pp. 2577-2583, (1983); 
Cavanagh D., Structural characterization of IBV glycoproteins Adv, Exp. Med. Biol., 173, pp. 95-108, (1984); 
Cavanagh D., Structural polypeptides of coronavirus IBV, J. Gen. Virol., 53, pp. 93-103, (1981); 
Cavanagh D., Davis P.J., Coronavirus IBV: Removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells, J. Gen. Virol., 67, pp. 1443-1448, (1986); 
Cavanagh D., Mawditt K., Adzhar A., Gough R.E., Picault J.P., Naylor C.J., Haydon D., Shaw K., Britton P., Does IBV change slowly despite the capacity of the spike protein to vary greatly?, Adv. Exp. Med. Biol., 440, pp. 729-734, (1998); 
Chang C.C., Yoon K.J., Zimmerman J.J., Harmon K.M., Dixon P.M., Dvorak C.M., Murtaugh M.P., Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs, J. Virol., 76, pp. 4750-4763, (2002); 
Eigen M., Self-organization of matter and the evolution of biological macromolecules, Die Naturwissenschaften, 58, (1971); 
Eigen M., On the nature of virus quasispecies, Trends in Microbiology, 4, pp. 216-217, (1996); 
Eigen M., Schuster P., The hypercycle. A principle of natural self-organization, Naturwissenschaften, 64, pp. 541-565, (1977); 
Enjuanes L., Brian D., Cavanagh D., Holmes K., Lai M.M.C., Laude H., Masters P., Rottier P., Siddell S.G., Spaan W.J.M., Taguchi F., Talbot P., Coronaviridae, Virus Taxonomy. Classification and Nomenclature of Viruses, pp. 835-849, (2000); 
Enjuanes L., Spaan W.J., Snijder E.J., Cavanagh D., Nidovirales, Virus Taxonomy. Classification and Nomenclature of Viruses, pp. 827-834, (2000); 
Fang S.G., Shen S., Tay F.P., Liu D.X., Selection of and recombination between minor variants lead to the adaptation of an avian coronavirus to primate cells, Biochem. Biophys. Res. Comm., 336, pp. 417-423, (2005); 
Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J., The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system, Virology, 187, pp. 178-188, (1992); 
Gallardo R.A., Van Santen V.L., Toro H., Host intraspatial selection of infectious bronchitis virus populations, Avian Dis., 54, pp. 807-813, (2010); 
Gallardo R.A., Van Santen V.L., Toro H., Effects of chicken anemia virus and infectious bursal disease virus-induced immunodeficiency on infectious bronchitis virus replication and phenotypic drift, Avian Pathol, (2012); 
Gavrilin G.V., Cherkasova E.A., Lipskaya G.Y., Kew O.M., Agol V.I., Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: A unifying model, J. Virol., 74, pp. 7381-7390, (2000); 
Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L., Daly J.M., Mumford J.A., Holmes E.C., Unifying the epidemiological and evolutionary dynamics of pathogens, Science, 303, pp. 327-332, (2004); 
Haller B.L., Barkon M.L., Li X.Y., Hu W.M., Wetzel J.D., Dermody T.S., Virgin IV H.W., Virgin IV. Brain-and intestine-specific variants of reovirus serotype 3 strain Dearing are selected during chronic infection of severe combined immunodeficient mice, J. Virol., 69, pp. 3933-3937, (1995); 
Hingley S.T., Gombold J.L., Lavi E., Weiss S.R., MHV-A59 fusion mutants are attenuated and display altered hepatotropism, Virology, 200, pp. 1-10, (1994); 
Hodgson T., Casais R., Dove B., Britton P., Cavanagh D., Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity, J. Virol., 78, pp. 13804-13811, (2004); 
Hoerr F.J., Clinical aspects of immunosuppression in poultry, Avian Dis, 54, pp. 2-15, (2010); 
Jackwood M.W., Boynton T.O., Hilt D.A., McKinley E.T., Kissinger J.C., Paterson A.H., Robertson J., Lemke C., McCall A.W., Williams S.M., Jackwood J.W., Byrd L.A., Emergence of a group 3 coronavirus through recombination, Virology, 398, pp. 98-108, (2010); 
Jackwood M.W., Hilt D.A., McCall A.W., Polizzi C.N., McKinley E.T., Williams S.M., Infectious bronchitis virus field vaccination coverage and persistence of Arkansas-type viruses in commercial broilers, Avian Dis., 53, pp. 175-183, (2009); 
Jungherr E.I., Chomiak T.W., Luginbuhl R.E., Immunologic Differences in Strains of Infectious Bronchitis Virus, Proc.s 60th Annual Meeting U.S. Livestock Sanitary Association, pp. 203-209, (1956); 
Kilbourne E.D., Host Determination of Viral Evolution: A Variable Tautology, The Evolutionary Biology of Viruses, pp. 253-271, (1994); 
Kimura M., The Neutral Theory of Molecular Evolution, (1983); 
Koch G., Hartog L., Kant A., Van Roozelaar D.J., Antigenic domains on the peplomer protein of avian infectious bronchitis virus: Correlation with biological functions, J. Gen. Virol., 71, pp. 1929-1935, (1990); 
Koch G., Kant A., Binding of antibodies that strongly neutralise infectious bronchitis virus is dependent on the glycosylation of the viral peplomer protein, Adv. Exp. Med. Biol., 276, pp. 143-150, (1990); 
Kottier S.A., Cavanagh D., Britton P., First experimental evidence of recombination in infectious bronchitis virus, Adv. Exp. Med. Biol., 380, pp. 551-556, (1995); 
Kusters J.G., Jager E.J., Niesters H.G., Zeijst Der Van B.A., Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus, Vaccine, 8, pp. 605-608, (1990); 
Kusters J.G., Niesters H.G., Bleumink-Pluym N.M., Davelaar F.G., Horzinek M.C., Zeijst Der Van B.A., Molecular epidemiology of infectious bronchitis virus in the Netherlands, J. Gen. Virol., 68, pp. 343-352, (1987); 
Kusters J.G., Niesters H.G.M., Lenstra J.A., Horzinek M.C., Van Der Zeijst B.A.M., Phylogeny of antigenic variants of avian coronavirus IBV, Virology, 169, pp. 217-221, (1989); 
Lai M.M.C., Cavanagh D., The molecular biology of coronaviruses, Adv. Vir. Res., 48, pp. 1-100, (1997); 
Lai M.M.C., Holmes K.V., Coronaviridae: The viruses and their replication, Fundamental Virology, pp. 641-663, (2001); 
Lee C.W., Hilt D.A., Jackwood M.W., Identification and analysis of the Georgia 98 serotype, a new serotype of infectious bronchitis virus, Avian Dis., 45, pp. 164-172, (2001); 
Leparc-Goffart I., Hingley S.T., Chua M.M., Jiang X., Lavi E., Weiss S.R., Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein, Virology, 269, pp. 1-10, (1997); 
Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., Farzan M., Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2, EMBO J., 24, pp. 1634-1643, (2005); 
Liu S., Han Z., Chen J., Liu X., Shao Y., Kong X., Tong G., Rong J., S1 gene sequence heterogeneity of a pathogenic infectious bronchitis virus strain and its embryo-passaged, attenuated derivatives, Avian Pathol., 36, pp. 231-234, (2007); 
Maginnis M.S., Haley S.A., Gee G.V., Atwood W.J., Role of N-linked glycosylation of the 5-HT 2A receptor in JC virus infection, J. Virol., 84, pp. 9677-9684, (2010); 
Martin J., Dunn G., Hull R., Patel V., Minor P.D., Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion, J. Virol., 74, pp. 3001-3010, (2000); 
Mase M., Tsukamoto K., Imai K., Yamaguchi S., Phylogenetic analysis of avian infectious bronchitis virus strains isolated in Japan, Arch. Virol., 149, pp. 2069-2078, (2004); 
Mayr E., Toward A New Philosophy of Biology Harvard, (1988); 
McKinley E.T., Hilt D.A., Jackwood M.W., Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination, Vaccine, 26, pp. 1274-1284, (2008); 
McKinley E.T., Jackwood M.W., Hilt D.A., Kissinger J.C., Robertson J.S., Lemke C., Paterson A.H., Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus, Virus Res., 158, pp. 225-234, (2011); 
McMinn P., Carrello A., Cole C., Baker D., Hampson A., Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community, Clin. Infec. Dis., 29, pp. 456-458, (1999); 
Minskaia E., Discovery of an RNA virus 39R59 exoribonuclease that is critically involved in coronavirus RNA synthesis, Proc. Natl. Acad. Sci. U. S. A., 103, pp. 5108-5113, (2006); 
Mockett A.P., Cavanagh D., Brown T.D., Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41, J. Gen. Virol., 65, pp. 2281-2286, (1984); 
Montassier H.J., Molecular epidemiology and evolution of avian infectious bronchitis virus, Rev. Bras. Cienc. Avic., 12, pp. 87-96, (2010); 
Moore M.J., Silver P.A., Global analysis of mRNA splicing, RNA, 14, pp. 197-203, (2008); 
Navas S., Seo S.H., Chua M.M., Sarma J.D., Hingley S.T., Lavi E., Weiss S.R., Role of the spike protein in murine coronavirus induced hepatitis: An in vivo study using targeted RNA recombination, Adv. Exp. Med. Biol., 494, pp. 139-144, (2001); 
Nix W.A., Troeber D.S., Kingham B.F., Keeler Jr.C.L., Gelb Jr.J., Emergence of subtype strains of the Arkansas serotype of infectious bronchitis virus in Delmarva broiler chickens, Avian Dis., 44, pp. 568-581, (2000); 
Ontiveros E., Kim T.S., Gallagher T.M., Perlman S., Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein, J. Virol., 77, pp. 10260-10269, (2003); 
Pessoa M.G., Bzowej N., Berenguer M., Phung Y., Kim M., Ferrell L., Hassoba H., Wright T.L., Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation, Hepatology, 30, pp. 1513-1520, (1999); 
Phillips J.E., Jackwood M.W., McKinley E.T., Thor S.W., Hilt D.A., Acevedol N.D., Williams S.M., Kissinger J.C., Paterson A.H., Robertson J.S., Lemke C., Changes in nonstructural protein 3 are associated with attenuation in avian coronavirus infectious bronchitis virus, Virus Genes, 44, pp. 63-74, (2011); 
Phillips J.J., Chua M., Seo S.H., Weiss S.R., Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence, J. Neurovirol., 7, pp. 421-431, (2001); 
Phillips J.J., Chua M.M., Rall G.F., Weiss S.R., Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system, Virology, 301, pp. 109-120, (2002); 
Rocha E., Cox N.J., Black R.A., Harmon M.W., Harrison C.J., Kendal A.P., Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child, J. Virol., 65, pp. 2340-2350, (1991); 
Schalk A.F., Hawn M.C., An apparently new respiratory disease of baby chicks, J. Am. Vet. Med. Assoc., 78, pp. 413-422, (1931); 
Shimazaki Y., Horiuchi T., Harada M., Tanimura C., Seki Y., Kuroda Y., Yagyu K., Nakamura S., Suzuki S., Isolation of 4/91 type of infectious bronchitis virus as a new variant in Japan and efficacy of vaccination against 4/91 type field isolate, Avian Dis., 52, pp. 618-622, (2008); 
Sperry S.M., Kazi L., Graham R.L., Baric R.S., Weiss S.R., Denison M.R., Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice, J. Virol., 79, pp. 3391-3400, (2005); 
Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H.-D., Rappuoli R., Comparison of coronavirus genome structures, Nature Rev. Microbiol., 1, pp. 209-218, (2003); 
Toro H., Pennington D., Gallardo R.A., Van Santen V.L., Van Ginkel F.W., Zhang J.F., Joiner K.S., Infectious bronchitis virus subpopulations in vaccinated chickens after challenge, Avian Dis., 56, pp. 501-508, (2012); 
Toro H., Van Santen V.L., Li L., Lockaby S.B., Van Santen E., Hoerr F.J., Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis, Avian Pathol., 35, pp. 1-10, (2006); 
Trebbien R., Larsen L.E., Viuff B.M., Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs, Virol. J., 8, pp. 434-448, (2011); 
Van Santen V.L., Ndegwa E.N., Joiner K.S., Toro H., Van Ginkel F.W., Significance of minor viral subpopulations within Ark-type infectious bronchitis vaccines, 6th International Symposium on Avian Corona-and Pneumoviruses and Complicating Pathogens, (2009); 
Van Santen V.L., Toro H., Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines, Avian Pathol., 37, pp. 293-306, (2008); 
Wesley R.D., Woods R.D., Cheung A.K., Genetic analysis of porcine respiratory coronavirus, an attenuated variant of transmissible gastroenteritis virus, J. Virol., 65, pp. 3369-3373, (1991); 
Wickramasinghe I.N., De Vries R.P., Grone A., De Haan C.A., Verheije M.H., Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity, J. Virol., 85, pp. 8903-8912, (2011); 
Zust R., Cervantes-Barragan L., Kuri T., Blakqori G., Weber F., Ludewig B., Thiel V., Coronavirus non-structural protein 1 is a major pathogenicity factor: Implications for the rational design of coronavirus vaccines, PLoS Pathog., 3, (2007)#FRF#
